ATED Therapeutics, Ltd.: New Rapid, Simple Blood Test for Parkinson’s Disease Developed

The new test can be used to identify pre-symptomatic patients with Parkinson’s disease and can measure progression of the disease. GREENWICH, Conn. & JERUSALEM–(BUSINESS WIRE)–ATED Therapeutics Ltd. announced a new diagnostic test for Parkinson’s Disease, developed at Hebrew University in Jerusalem, Israel. The test measures transfer RNA fragments (tRF’s) from nucleated red blood cells. Results … [Read more…]

Oxford Nanopore Expands Compatible Products Programme and Strengthens Multi-Omics Ecosystem

Multiple new partnerships with approved products announced to support broader access to flexible, end-to-end sequencing applications. OXFORD, England–(BUSINESS WIRE)–#Nanopore–Oxford Nanopore Technologies today announced the expansion of its Compatible Products Programme (CPP), welcoming a new cohort of leading partners whose products now integrate seamlessly with Oxford Nanopore’s rapid, information-rich, accessible and affordable molecular sensing technology. First … [Read more…]

AdvanCell Proudly Announces $18M in Federal Funding from the Medical Research Future Fund (MRFF) Frontiers Initiative for ‘Defeating Prostate Cancer with Targeted Alpha Therapy’

SYDNEY–(BUSINESS WIRE)–AdvanCell, a clinical-stage radiopharmaceutical company developing innovative cancer therapeutics, today announced $18M in Australian Federal Government Funding from the Medical Research Future Fund (MRFF) Frontiers Initiative for ‘Defeating Prostate Cancer with Targeted Alpha Therapy’. One out of eight men develops prostate cancer. With the support from the Medical Research Future Fund (MRFF) Frontiers Initiative, … [Read more…]

Soleus Capital Issues Letter to The Board of Theratechnologies

GREENWICH, Conn.–(BUSINESS WIRE)–Soleus Capital Management, L.P. (“Soleus Capital”), a healthcare investment firm which owns in excess of 10% of the stock of Theratechnologies Inc. (NASDAQ: THTX) (the “Company”), today sent a letter to the Board of Directors of the Company. In its letter, Soleus Capital described its belief that an acquisition of the Company is … [Read more…]

Digital Connectivity for Tribal Veterans: Televeda, ADVS, and Navajo Nation Partner to Expand Access to Benefits, Peer Support, and Traditional Healing

PHOENIX–(BUSINESS WIRE)–Indigenous veterans have honorably served in the U.S. Armed Forces for generations, yet many still face barriers to healthcare, peer support, and culturally aligned services due to limited internet access in rural communities. To address these disparities, the Arizona Department of Veterans’ Services and Televeda have launched the Tribal Connectivity Project, “Roger That,” a … [Read more…]

ZYUS Life Sciences Corporation Announces Issuance of Bonus Warrants Pursuant to Loan Agreements

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES SASKATOON, Saskatchewan–(BUSINESS WIRE)–ZYUS Life Sciences Corporation (the “Company”) (TSX-V: ZYUS), a Canadian-based life sciences company focused on the development and commercialization of novel cannabinoid-based pharmaceutical drug candidates for pain management, announces that it has received conditional acceptance from the TSX … [Read more…]

U.S. Food and Drug Administration Approves Opdivo® (nivolumab) plus Yervoy® (ipilimumab) as a First-Line Treatment for Unresectable or Metastatic Hepatocellular Carcinoma

Based on the Phase 3 CheckMate-9DW trial, Opdivo plus Yervoy demonstrated a statistically significant overall survival benefit compared to investigator’s choice of lenvatinib or sorafenib1 In the trial, 38% of patients were still alive at 3 years with this dual immunotherapy vs. 24% with the comparator arm1 PRINCETON, N.J.–(BUSINESS WIRE)–$BMY #BMS—Bristol Myers Squibb (NYSE: BMY) … [Read more…]

CEUS Offers Safe, Useful Diagnostic Imaging Option for Pregnant Women

CALGARY, Alberta–(BUSINESS WIRE)–#CEUS–Contrast-enhanced ultrasound (CEUS) is a safe and accurate diagnostic imaging option for pregnant women who develop a medical problem or a suspicious tumor that typically would be investigated by a contrast enhanced CT or MR scan, according to a new study by Canadian doctors. “CEUS is well tolerated by pregnant patients and provides … [Read more…]

Future Pak Submits Proposals to Acquire Theratechnologies Inc., Offering up to $255 Million in Total Value

WIXOM, Mich.–(BUSINESS WIRE)–Future Pak, LLC (“Future Pak”) today announced that it has submitted two formal proposals since January to acquire all outstanding shares of common stock of Theratechnologies Inc. (“Theratechnologies”) (NASDAQ: THTX). The most recent proposal, which remains open for consideration by Theratechnologies and its Board of Directors, offers a cash consideration of $3.51 to … [Read more…]

Predictmedix AI Screening Technology Emerges as Strategic Asset Amid FDA’s Regulatory Shift Away from Animal Testing

TORONTO–(BUSINESS WIRE)–Predictmedix AI Inc. (CSE: PMED) (OTC: PMEDF) (FRA: 3QP) (“Predictmedix” or the “Company”), a leading provider in AI-driven health and safety solutions, welcomes the U.S. Food and Drug Administration’s (FDA) groundbreaking move to phase out mandatory animal testing in drug development. As the pharmaceutical and biotech industries pivot toward more ethical and technologically advanced … [Read more…]